Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody
Research Grade
Reactivity: Human
FACS
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all KIR2DL2 (Lirilumab Biosimilar) products
- KIR2DL2 (Lirilumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS)
- Purpose
- Anti-KIR2DL2 (lirilumab biosimilar) mAb
- Characteristics
- BMS-986015, IPH2102
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Grade
- Research Grade
- Isotype
- IgG4
-
-
- Application Notes
- Flow Cyt 1:100
- Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Expiry Date
- 12 months
-
- Target
- KIR2DL2 (Lirilumab Biosimilar)
- Abstract
- KIR2DL2 (Lirilumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: CD158b, CD158B1, NKAT-6, NKAT6, p58.2
- UniProt
- P43627
-
You are here:
